DB05203ExperimentalSmall molecule
SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
- Primary indication
- Investigated for use/treatment in hypertension.Curator reviewed
- Code names
- SPP1148
Resolves to
Targets
What you can answer from here — as of April 02, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with SPP1148, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account